GlassScriptPhysician profile
John V Houghtaling
NPI 1063661262
$6,725.26
in general payments reported to CMS, 2019-2025
21 companies · $230 in 2025
The $230 reported for 2025 was less than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2020: $64.40 · 2021: $249 · 2022: $4,795 · 2023: $205 · 2024: $998 · 2025: $230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $925 · Travel and Lodging: $508.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $924.91 |
| Travel and Lodging | $508.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $4,990.99 | 2019-2024 | Xiaflex |
| Sonex Health, INC. | $765.91 | 2024 | Sx-One Microknife |
| Pacira Therapeutics, INC. | $129.08 | 2019-2021 | |
| Endo USA, INC. | $127.47 | 2024-2025 | Xiaflex |
| Rock Medical Orthopedics, INC. | $95.17 | 2022-2023 | |
| Ets Wound Care LLC | $85.02 | 2024 | Mirragen Advanced Wound Matrix |
| Zimmer Biomet Holdings, INC. | $82.88 | 2019-2025 | Tapestry |
| Nexus Medical Technologies LLC | $81.76 | 2024-2025 | |
| Bioventus LLC | $68.29 | 2020-2024 | Gelsyn-3, Exogen Ultrasound Bone Healing System |
| Stryker Corporation | $44.50 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $43.60 | 2020-2025 | Exparel |
| Si-Bone, INC. | $29.46 | 2021 | |
| Avanos Medical | $27.47 | 2025 | On-Q Pump and Accessories |
| Abbott Laboratories | $25.17 | 2019 | |
| Ethicon US, LLC | $23.60 | 2024 | Surgicel Nu-Knit |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $22.84 | 2023 | Tenoglide |
| Vertex Pharmaceuticals Incorporated | $21.09 | 2025 | |
| Axogen | $19.67 | 2021 | |
| Heron Therapeutics, INC. | $17.22 | 2023 | Zynrelef |
| Sanofi-Aventis U.S. LLC | $15.83 | 2023 | |
| Checkpoint Surgical, INC | $8.24 | 2023 | Checkpoint Stimulators |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Houghtaling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.